Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology

Trends in Molecular Medicine

Volumn 10, Issue 1, 2004, Pages 19-23

  Cinatl, Jindrich ^a   Scholz, Martin ^a   Kotchetkov, Rouslan ^a   Vogel, Jens Uwe ^a   Doerr, Hans Wilhelm ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TUMOR ANTIGEN;

ANGIOGENESIS; APOPTOSIS; CANCER INHIBITION; CANCER TISSUE; CARCINOMA; CELL MIGRATION; COLON CANCER; CYTOLOGY; CYTOMEGALOVIRUS INFECTION; DATA ANALYSIS; DISEASE ASSOCIATION; EXPERIMENT; GENOME ANALYSIS; GLIOBLASTOMA; HOST CELL; HUMAN; HUMAN CYTOMEGALOVIRUS; MOLECULAR MECHANICS; NONHUMAN; PATHOGENESIS; PROSTATE TUMOR; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR CELL LINE; TUMOR GROWTH; VIRUS GENOME;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0742304301     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2003.11.002     Document Type: Article

References (29)

1. Cinatl J. Jr, et al. Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology. 39:1996;259-269.
2. Cinatl J. Jr, et al. Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells. Cancer Res. 58:1998;367-372.
3. Cinatl J. Jr, et al. Long-term productive human cytomegalovirus infection of a human neuroblastoma cell line. Int. J. Cancer. 65:1996;90-96.
4. Harkins L., et al. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet. 360:2002;1557-1563.
5. Cobbs C.S., et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 62:2002;3347-3350.
6. Huang G., et al. Human cytomegalovirus in neoplastic cells of Epstein-Barr virus negative Hodgkin's disease. Int. J. Oncol. 21:2002;31-36.
7. Samanta M., et al. High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J. Urol. 170:2003;998-1002.
8. Skaletskaya A., et al. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc. Natl. Acad. Sci. U. S. A. 98:2001;7829-7834.
9. McCormick A.L., et al. Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis. J. Virol. 77:2003;631-641.
10. Allart S., et al. Human cytomegalovirus induces drug resistance and alteration of programmed cell death by accumulation of ΔN-p73α J. Biol. Chem. 277:2002;29063-29068.
11. Yu Y., Alwine J.C. Human cytomegalovirus major immediate-early proteins and simian virus 40 large T antigen can inhibit apoptosis through activation of the phosphatidylinositide 3′-OH kinase pathway and the cellular kinase Akt. J. Virol. 76:2002;3731-3738.
12. Baillie J., et al. Human cytomegalovirus infection inhibits tumor necrosis factor α (TNF-α) signaling by targeting the 55-kiloDalton TNF-α receptor. J. Virol. 77:2003;7007-7016.
13. Streblow D.N., et al. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell. 99:1999;511-520.
14. Shinmura Y., et al. Migration of virus-infected neuronal cells in cerebral slice cultures of developing mouse brains after in vitro infection with murine cytomegalovirus. Acta Neuropathol. (Berl.). 98:1999;590-596.
15. Scholz M., et al. Cytomegalovirus-infected neuroblastoma cells exhibit augmented invasiveness mediated by β1α5 integrin (VLA-5). Tissue Antigens. 55:2000;412-421.
16. Scholz M., et al. Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option? Antiviral Res. 49:2001;129-145.
17. Alcami J., et al. Induction of an endothelial cell growth factor by human cytomegalovirus infection of fibroblasts. J. Gen. Virol. 72:1991;2765-2770.
18. Cinatl J. Jr, et al. Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53. Am. J. Pathol. 155:1999;285-292.
19. Cinatl J. Jr, et al. Cytomegalovirus infection decreases expression of thrombospondin-1 and -2 in cultured human retinal glial cells: effects of antiviral agents. J. Infect. Dis. 182:2000;643-651.
20. Nabors L.B., et al. Tumor necrosis factor α induces angiogenic factor up-regulation in malignant glioma cells: a role for RNA stabilization and HuR. Cancer Res. 63:2003;4181-4187.
21. Murayama T., et al. The immediate early gene 1 product of human cytomegalovirus is sufficient for up-regulation of interleukin-8 gene expression. Biochem. Biophys. Res. Commun. 279:2000;298-304.
22. Maisch T., et al. Upregulation of CD40 expression on endothelial cells infected with human cytomegalovirus. J. Virol. 76:2002;12803-12812.
23. Johnson R.A., et al. Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J. Virol. 75:2001;6022-6032.
24. Boyle K.A., et al. Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway. Mol. Cell. Biol. 19:1999;3607-3613.
25. Johnson R.A., et al. Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38. J. Virol. 74:2000;1158-1167.
26. Johnson R.A., et al. The role of MKK1/2 kinase activity in human cytomegalovirus infection. J. Gen. Virol. 82:2001;493-497.
27. Shibutani T., et al. Pertussis toxin-sensitive G proteins as mediators of the signal transduction pathways activated by cytomegalovirus infection of smooth muscle cells. J. Clin. Invest. 100:1997;2054-2061.
28. Wang X., et al. Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature. 424:2003;456-461.
29. Compton T., et al. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol. 77:2003;4588-4596.